RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
Adam17
ADAM metallopeptidase domain 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24548422
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:40,872,856...40,920,639
G
Adipoq
adiponectin, C1Q and collagen domain containing
IEP ISO
RGD
PMID:17604368 PMID:21479819
RGD:5686754 , RGD:5686898
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adk
adenosine kinase
ISO
RGD
PMID:11123368
RGD:6482664
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,863,244...3,246,510
G
Adrb3
adrenoceptor beta 3
IEP
mRNA:decreased expression:distal colon, mucosa (rat)
RGD
PMID:18492028
RGD:5684890
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:64,841,788...64,844,552
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27783946
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15821759
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Anxa1
annexin A1
IEP
protein:increased expression:colon, neutrophil
RGD
PMID:10489933
RGD:2306920
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:217,861,175...217,877,343
G
Apln
apelin
IEP
RGD
PMID:17391779
RGD:1626177
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:127,203,823...127,213,391
G
Apoa4
apolipoprotein A4
ISO
human protein in mouse model
RGD
PMID:15254593
RGD:5685667
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Aqp7
aquaporin 7
ISO
associated with Infection;mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:56,172,519...56,186,642
G
Arg1
arginase 1
severity
ISO
RGD
PMID:28423665
RGD:39939041
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:20,475,968...20,488,422
G
Arrb1
arrestin, beta 1
IEP
protein:increased expression:colon (rat)
RGD
PMID:21066892
RGD:5509893
NCBI chr 1:163,249,654...163,321,711
Ensembl chr 1:153,838,078...153,904,061
G
Atp5f1d
ATP synthase F1 subunit delta
treatment
IEP
RGD
PMID:23840258
RGD:13792680
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:9,560,608...9,565,929
G
Bdnf
brain-derived neurotrophic factor
ISO
protein:increased expression:dorsal root ganglion:
RGD
PMID:19932037
RGD:8657331
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bmp6
bone morphogenetic protein 6
IEP
RGD
PMID:22361727
RGD:7242194
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,318,569...26,470,365
G
Btk
Bruton tyrosine kinase
ameliorates
ISO
Associated with candidiasis
RGD
PMID:25379804
RGD:124713568
NCBI chr X:102,016,070...102,055,448
Ensembl chr X:97,722,802...97,761,853
G
Car1
carbonic anhydrase 1
IEP
protein:decreased expression:urine
RGD
PMID:31095872
RGD:408427353
NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:86,861,897...86,872,208
G
Cat
catalase
IDA
RGD
PMID:21463646
RGD:5130869
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cckbr
cholecystokinin B receptor
IMP
RGD
PMID:15102523
RGD:2311333
NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:159,771,733...159,814,881
G
Ccl2
C-C motif chemokine ligand 2
IEP
RGD
PMID:18690297
RGD:2307009
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccr1
C-C motif chemokine receptor 1
IMP
RGD
PMID:16399111
RGD:2307162
NCBI chr 8:132,433,711...132,439,266
G
Cd36
CD36 molecule
ISO
RGD
PMID:19117124
RGD:6893503
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
IMP
RGD
PMID:15591506
RGD:5508169
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Chek2
checkpoint kinase 2
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:10617473 PMID:11053450 PMID:11479205 PMID:11719428 PMID:11967536 PMID:12094328 PMID:12533788 PMID:12690581 PMID:14648717 PMID:14648718 PMID:14648719 PMID:15087378 PMID:15095295 PMID:15122511 PMID:15466005 PMID:15488637 PMID:15492928 PMID:15520402 PMID:16257342 PMID:16492927 PMID:16880452 PMID:17085682 PMID:18172190 PMID:18381420 PMID:18759107 PMID:19338683 PMID:19768534 PMID:19805189 PMID:21779515 PMID:21807500 PMID:21876083 PMID:21956126 PMID:22006311 PMID:22058428 PMID:22419737 PMID:22811390 PMID:22994785 PMID:23109706 PMID:23469205 PMID:23652375 PMID:23946381 PMID:24033266 PMID:24713400 PMID:24884479 PMID:25431674 PMID:25583358 PMID:25741868 PMID:26467025 PMID:26845104 PMID:26884562 PMID:26976419 PMID:27223485 PMID:27269948 PMID:27433846 PMID:27711073 PMID:27751358 PMID:27798748 PMID:28135145 PMID:28195393 PMID:28492532 PMID:28503720 PMID:28514723 PMID:28727877 PMID:28734145 PMID:28779002 PMID:28802053 PMID:28874143 PMID:29351919 PMID:29489754 PMID:29522266 PMID:29909568 PMID:31300551 PMID:31993860 PMID:32119081 PMID:32285038 PMID:32295079 PMID:32383162 PMID:32531112 PMID:33471991 PMID:35534704 PMID:36222830 PMID:36623239 PMID:36744932 PMID:37055167 PMID:37149759 More...
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
treatment
IEP
RGD
PMID:17543437
RGD:2298659
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
G
Ciita
class II, major histocompatibility complex, transactivator
severity
ISO
protein:increased expression:T cells:constitutive expression of transgene increases severity (mouse) ClinVar Annotator: match by term: Colitis
ClinVar RGD
PMID:25741868 PMID:28492532 PMID:17043423
RGD:5491188
NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,140,178...5,187,440
G
Crhr2
corticotropin releasing hormone receptor 2
IEP IMP
mRNA, protein:decreased expression:intestine, myenteric nerve plexus
RGD
PMID:17586086 PMID:21330446
RGD:5131259 , RGD:5490987
NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:84,224,002...84,265,904
G
Ctsb
cathepsin B
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Ctsl
cathepsin L
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr17:770,104...776,266
Ensembl chr17:764,309...770,548
G
Ctss
cathepsin S
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:183,086,437...183,114,483
G
Cxcr2
C-X-C motif chemokine receptor 2
IMP
RGD
PMID:14738862
RGD:7257706
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:75,729,115...75,739,425
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
mRNA:increased expression:large intestine epithelium
RGD
PMID:21374063
RGD:5147670
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Dusp1
dual specificity phosphatase 1
severity
ISO
RGD
PMID:22461024
RGD:7771532
NCBI chr10:17,184,853...17,187,646
G
Esr2
estrogen receptor 2
IEP ISO
mRNA:decreased expression:colon
RGD
PMID:21252046 PMID:21252046
RGD:5508810 , RGD:5508810
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Fgf19
fibroblast growth factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27580383
NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:200,056,644...200,060,287
G
Flna
filamin A
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:25741868 PMID:28492532 PMID:30755392
NCBI chr X:157,159,051...157,185,559
Ensembl chr X:152,007,758...152,031,052
G
Gcg
glucagon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22323126
NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:47,113,914...47,122,929
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19617644
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:146,865,712...146,869,621
G
Gsta4
glutathione S-transferase alpha 4
ISO
protein:increased expression:colon, epithelial cell (mouse)
RGD
PMID:15309552
RGD:5687963
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:79,066,934...79,084,182
G
Havcr1
hepatitis A virus cellular receptor 1
IEP
mRNA:increased expression:kidney:
RGD
PMID:23307618
RGD:7245473
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
G
Hmox1
heme oxygenase 1
treatment
IEP ISO
protein:increased expression:colon: CTD Direct Evidence: therapeutic
CTD RGD
PMID:16365149 PMID:21444764 PMID:22261574 PMID:21853095
RGD:7207796 , RGD:10766442
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
treatment
IEP
RGD
PMID:22457771
RGD:11041866
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Icam1
intercellular adhesion molecule 1
IEP
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Icos
inducible T-cell co-stimulator
IEP
protein:increased expression:T-cell
RGD
PMID:14731127
RGD:1624274
NCBI chr 9:69,862,042...69,900,864
Ensembl chr 9:62,383,832...62,405,672
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24548422 PMID:16717119
RGD:150573704
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24782617
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
IEP
RGD
PMID:17543437
RGD:2298659
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:19238344 PMID:21807089 PMID:22119709 PMID:24314293 PMID:21949848 PMID:22461024 PMID:23771723 More...
RGD:7349385 , RGD:7771532 , RGD:7365024
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il17a
interleukin 17A
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:colon
CTD RGD
PMID:24548422 PMID:14962796 PMID:20881082
RGD:4888509 , RGD:4781448
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Il1b
interleukin 1 beta
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23810507 PMID:24548422 PMID:22969190
RGD:7204699
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
severity
ISO
RGD
PMID:23172891
RGD:40400694
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:42,697,192...42,727,256
G
Il33
interleukin 33
severity
ISO
RGD
PMID:28423665 PMID:23172891
RGD:39939041 , RGD:40400694
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373
G
Il4
interleukin 4
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:24314293 PMID:9389741
RGD:8142400
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
ISO
protein: increased expression
RGD
PMID:22018693
RGD:5687148
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22410118 PMID:24548422
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Itgb2
integrin subunit beta 2
ISO
associated with Spirochaetales infections
RGD
PMID:11031123
RGD:6482227
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,061,430...11,097,600
G
Kdr
kinase insert domain receptor
IEP
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Lct
lactase
IEP
protein:decreased expression, increased expression:jejunum
RGD
PMID:17218984
RGD:1600240
NCBI chr13:42,334,347...42,376,872
Ensembl chr13:39,781,929...39,824,456
G
Lrrk2
leucine-rich repeat kinase 2
ISO
RGD
PMID:21983832
RGD:5508401
NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:122,826,696...122,987,703
G
Madcam1
mucosal vascular addressin cell adhesion molecule 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16917232
NCBI chr 7:10,686,920...10,690,322
Ensembl chr 7:10,036,301...10,039,703
G
Mc1r
melanocortin 1 receptor
ISO
RGD
PMID:16543288
RGD:5687320
NCBI chr19:68,360,950...68,363,877
Ensembl chr19:51,453,239...51,454,192
G
Mif
macrophage migration inhibitory factor
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12105854 PMID:17324399
RGD:1641979
NCBI chr20:12,767,138...12,791,222
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mir150
microRNA 150
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26937033
NCBI chr 1:104,741,487...104,741,571
Ensembl chr 1:95,605,024...95,605,108
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Msh2
mutS homolog 2
IEP
RGD
PMID:23883737
RGD:10412318
NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:6,813,795...6,872,938
G
Muc17
mucin 17, cell surface associated
treatment
IEP IDA
mRNA:increased expression:ileum, colon
RGD
PMID:16964428 PMID:23395625
RGD:1625545 , RGD:7349360
NCBI chr12:25,139,076...25,175,249
Ensembl chr12:19,527,321...19,538,522
G
Muc2
mucin 2, oligomeric mucus/gel-forming
treatment
IEP IDA ISO
mRNA:decreased expression:colon protein:decreased sulfation:descending colon
RGD
PMID:19220658 PMID:21949848 PMID:23395625 PMID:12395902
RGD:2324675 , RGD:7349385 , RGD:7349360 , RGD:7349356
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:196,799,517...196,831,756
G
Nampt
nicotinamide phosphoribosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:49,424,332...49,462,100
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:30142311
RGD:42724458
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nod1
nucleotide-binding oligomerization domain containing 1
ISO
RGD
PMID:20921147
RGD:5508755
NCBI chr 4:85,391,142...85,442,281
Ensembl chr 4:84,060,880...84,111,404
G
Nod2
nucleotide-binding oligomerization domain containing 2
IEP ISO
mRNA:increased expression:colon
RGD
PMID:16891783 PMID:20921147 PMID:21471573
RGD:1600781 , RGD:5508755 , RGD:5508727
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Nos2
nitric oxide synthase 2
IEP ISO
mRNA:increased expression:colon CTD Direct Evidence: marker/mechanism mRNA:increased expression:colon (mouse)
CTD RGD
PMID:8698225 PMID:17449036 PMID:16866779 PMID:21930116
RGD:4891411 , RGD:5509045
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
IEP
mRNA:increased expression:colon
RGD
PMID:17947450
RGD:2292124
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
IEP
mRNA, protein:increased expression:neuron
RGD
PMID:20638179
RGD:5684542
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:173,236,963...173,253,770
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
IEP
mRNA, protein:increased expression:dorsal root ganglion
RGD
PMID:20638179
RGD:5684542
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Pgf
placental growth factor
ISO
RGD
PMID:20142801
RGD:6483587
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
ISO
RGD
PMID:21244371
RGD:6482682
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:48,766,864...48,802,043
G
Pla2g2a
phospholipase A2 group IIA
ISO
RGD
PMID:17982090
RGD:6482729
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:151,076,442...151,079,014
G
Ppara
peroxisome proliferator activated receptor alpha
susceptibility
ISO
RGD
PMID:20650341
RGD:5509936
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppargc1a
PPARG coactivator 1 alpha
IDA
RGD
PMID:22126533
RGD:6484264
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
G
Ptger4
prostaglandin E receptor 4
ISO
RGD
PMID:20833794
RGD:6483551
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:54,335,424...54,346,670
G
Ptgs2
prostaglandin-endoperoxide synthase 2
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11820457 PMID:17543437
RGD:2298659
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
IEP ISO
protein:increased expression:nucleus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23810507 PMID:18623154
RGD:2298776
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Ren
renin
treatment
ISO
RGD
PMID:24858618
RGD:125097500
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
G
Retn
resistin
treatment
IDA
RGD
PMID:22630819
RGD:7207222
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
G
RT1-CE13
RT1 class I, locus CE13
ISO
human gene in rat model; DNA:polymorphisms:cds:HLA-B27 (human)
RGD
PMID:2257626
RGD:7387221
NCBI chr20:3,314,491...3,322,815
G
Sell
selectin L
IMP
RGD
PMID:18054560
RGD:5685703
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
IEP
protein:increased expression:colon
RGD
PMID:19147805
RGD:2312310
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Selplg
selectin P ligand
ISO
RGD
PMID:22009715
RGD:6218987
NCBI chr12:48,457,102...48,470,444
Ensembl chr12:42,796,580...42,812,585
G
Si
sucrase-isomaltase
IEP
mRNA, protein:decreased expression:ileum
RGD
PMID:16964428
RGD:1625545
NCBI chr 2:159,804,568...159,884,902
Ensembl chr 2:157,506,342...157,585,260
G
Sirt1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19940103 PMID:24548422 PMID:24782617
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Slc11a1
solute carrier family 11 member 1
ISO
RGD
PMID:19016783
RGD:5684975
NCBI chr 9:83,406,327...83,417,252
Ensembl chr 9:75,957,316...75,968,101
G
Socs1
suppressor of cytokine signaling 1
ISO
RGD
PMID:16717119
RGD:150573704
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17551092
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:146,091,841...146,139,476
G
Syk
spleen associated tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Colitis
CTD ClinVar
PMID:25741868 PMID:28492532 PMID:33782605
NCBI chr17:12,756,493...12,830,927
Ensembl chr17:12,604,619...12,661,410
G
Tac1
tachykinin, precursor 1
IEP
RGD
PMID:18715640
RGD:2304260
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
G
Tacr1
tachykinin receptor 1
IEP
RGD
PMID:18715640
RGD:2304260
NCBI chr 4:116,478,617...116,647,492
Ensembl chr 4:114,920,844...115,089,733
G
Tacr2
tachykinin receptor 2
IEP IMP
RGD
PMID:18715640 PMID:12490601
RGD:2304260 , RGD:5147478
NCBI chr20:30,751,645...30,766,181
Ensembl chr20:30,208,907...30,223,446
G
Tes
testin LIM domain protein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:39237074
NCBI chr 4:46,331,257...46,369,782
Ensembl chr 4:45,365,285...45,403,829
G
Tff1
trefoil factor 1
IEP
RGD
PMID:8836141
RGD:625375
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,235,736...9,239,597
G
Timp3
TIMP metallopeptidase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24548422
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:17,521,919...17,571,839
G
Tlr3
toll-like receptor 3
IEP
mRNA:increased expression:large intestine mucosa (rat)
RGD
PMID:20011045
RGD:5128708
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:46,822,039...46,836,545
G
Tlr4
toll-like receptor 4
IEP ISO
protein:increased expression:colon
RGD
PMID:19002562 PMID:19924809
RGD:2312573 , RGD:7794773
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507 PMID:24548422
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Trem1
triggering receptor expressed on myeloid cells 1
severity
ISO
RGD
PMID:24453980
RGD:126925972
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:12,763,819...12,779,203
G
Tst
thiosulfate sulfurtransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19647029
NCBI chr 7:111,828,557...111,836,980
Ensembl chr 7:109,948,062...109,957,216
G
Ucn
urocortin
IEP
mRNA:altered expression:distal colon (rat)
RGD
PMID:21330446
RGD:5490987
NCBI chr 6:30,958,086...30,958,916
Ensembl chr 6:25,238,120...25,238,950
G
Ucn2
urocortin 2
IEP
mRNA:increased expression:colon (rat)
RGD
PMID:17586086
RGD:5131259
NCBI chr 8:118,516,111...118,517,660
Ensembl chr 8:109,638,285...109,639,172
G
Vcam1
vascular cell adhesion molecule 1
IEP
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vip
vasoactive intestinal peptide
ISO
associated with Gram-Negative Bacterial Infections
RGD
PMID:19661153
RGD:5685605
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:42,065,120...42,073,216
G
Vipr2
vasoactive intestinal peptide receptor 2
ISO
RGD
PMID:21295288
RGD:5685384
NCBI chr 6:143,139,672...143,213,609
Ensembl chr 6:137,001,511...137,070,597
G
Ace
angiotensin I converting enzyme
ISO
protein:increased expression:small intestine, large intestine:extracellular space (mouse)
RGD
PMID:26401072
RGD:11555935
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Ace2
angiotensin converting enzyme 2
severity
ISO
Ace2 knockout Ace2 inhibitor
RGD
PMID:22837003 PMID:19517214
RGD:40818307 , RGD:40818410
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:28740344
RGD:13782278
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
ISO
RGD
PMID:28740344
RGD:13782278
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Serpina1
serpin family A member 1
treatment
ISO
RGD
PMID:23835442
RGD:14695050
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:122,866,312...122,888,339
G
Il23a
interleukin 23 subunit alpha
severity
ISO
RGD
PMID:26455347
RGD:11097134
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:721,809...723,923
G
Il33
interleukin 33
treatment severity
ISO
RGD
PMID:32156806 PMID:32156806
RGD:40400894 , RGD:40400894
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373
G
Ace
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:24239644 PMID:17342403
RGD:40400720 , RGD:40400748
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:90,910,316...90,931,131
G
Acer3
alkaline ceramidase 3
severity
ISO
mRNA,protein:decreased expression, decreased activity:colon:
RGD
PMID:26938296 PMID:26938296
RGD:35673322 , RGD:35673322
NCBI chr 1:161,915,397...162,017,802
Ensembl chr 1:152,504,186...152,606,591
G
Adam17
ADAM metallopeptidase domain 17
treatment
IEP
RGD
PMID:11884025
RGD:632022
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:40,872,856...40,920,639
G
Adrb3
adrenoceptor beta 3
no_association
IEP
mRNA:unaltered expression:colon (rat)
RGD
PMID:11803250
RGD:5684894
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:64,841,788...64,844,552
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
G
Akt1
AKT serine/threonine kinase 1
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Atm
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:20179206
RGD:126781749
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Atp5f1a
ATP synthase F1 subunit alpha
treatment
IEP
RGD
PMID:25689466
RGD:13703055
NCBI chr18:73,567,537...73,575,473
Ensembl chr18:71,292,374...71,300,794
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc3
baculoviral IAP repeat-containing 3
exacerbates
ISO
RGD
PMID:26037070
RGD:11537970
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
G
Cd68
Cd68 molecule
treatment
ISO
RGD
PMID:25004394
RGD:40925931
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,381,815...54,383,697
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
treatment
IMP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240
G
Csf1r
colony stimulating factor 1 receptor
ameliorates
ISO
RGD
PMID:23451116
RGD:150524300
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
G
Csf3
colony stimulating factor 3
treatment
ISO
RGD
PMID:16689657
RGD:11039462
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
G
Ereg
epiregulin
ISO
protein:increased expression:colonic mucosa (mouse)
RGD
PMID:20498653
RGD:39457688
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,027,287...17,041,062
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
ISO
RGD
PMID:31160593
RGD:126779602
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:76,624,399...76,687,362
G
Fas
Fas cell surface death receptor
treatment
IDA
RGD
PMID:22368862
RGD:10054108
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fgf10
fibroblast growth factor 10
treatment
ISO IDA
human protein in mouse model human gene product in mouse model human protein in mouse model with bacterial delivery system
RGD
PMID:10381813 PMID:11952999 PMID:23676805 PMID:19736360
RGD:126928132 , RGD:127284874 , RGD:127284855 , RGD:126928133
NCBI chr 2:52,533,939...52,610,980
Ensembl chr 2:50,800,992...50,876,866
G
Fgf7
fibroblast growth factor 7
treatment
ISO
human protein in mouse model
RGD
PMID:10219846
RGD:126928136
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:113,281,283...113,332,929
G
Foxp3
forkhead box P3
treatment
ISO IDA
mRNA:increased expression:mucosa: protein:increased expression:colon:
RGD
PMID:26925602 PMID:28733028 PMID:27498708 PMID:17229795
RGD:38455994 , RGD:38549362 , RGD:14975101 , RGD:38455995
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:14,908,494...14,923,838
G
Hamp
hepcidin antimicrobial peptide
IEP
protein:increased expression:colon
RGD
PMID:24764672
RGD:11041628
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Hmgb1
high mobility group box 1
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hsf1
heat shock transcription factor 1
IEP
protein:increased acetylation:colon (rat)
RGD
PMID:25608526
RGD:10402402
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:108,196,056...108,223,011
G
Icam1
intercellular adhesion molecule 1
treatment
IMP IEP
RGD
PMID:10092309 PMID:29572553
RGD:11522714 , RGD:152995414
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
IEP ISO
protein:increased expression:plasma:
RGD
PMID:15030379 PMID:27498708
RGD:10755756 , RGD:14975101
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:14,333,187...14,351,785
G
Il10
interleukin 10
treatment
ISO IEP
associated with Helicobacter Infections
RGD
PMID:16982822 PMID:29572553 PMID:27815529 PMID:25727887
RGD:11049170 , RGD:152995414 , RGD:14975260 , RGD:11049485
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il1b
interleukin 1 beta
treatment
ISO
RGD
PMID:31175857
RGD:14975282
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8978354
RGD:8551835
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
IEP
RGD
PMID:16630696
RGD:8662978
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il23a
interleukin 23 subunit alpha
severity
ISO
mRNA:increased expression:colon (mouse)
RGD
PMID:24028683
RGD:39458035
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:721,809...723,923
G
Il25
interleukin 25
treatment
ISO
RGD
PMID:19118508
RGD:39456129
NCBI chr15:32,378,750...32,382,141
Ensembl chr15:28,408,842...28,411,893
G
Il33
interleukin 33
severity treatment
ISO
RGD
PMID:25112700 PMID:28423665
RGD:39938951 , RGD:39939041
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373
G
Il6
interleukin 6
treatment
IEP ISO IDA
RGD
PMID:16630696 PMID:27096537 PMID:16133010
RGD:8662978 , RGD:11062146 , RGD:11062139
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Irf9
interferon regulatory factor 9
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:29,095,789...29,101,236
G
Itga2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:16534417
RGD:11530069
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
G
Itga4
integrin subunit alpha 4
IEP
protein:increased expression:colon (rat)
RGD
PMID:12183646
RGD:729408
NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:64,163,085...64,233,715
G
Jak2
Janus kinase 2
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Kcnma1
potassium calcium-activated channel subfamily M alpha 1
IEP
mRNA, protein:increased expression:colon
RGD
PMID:23986198
RGD:10412026
NCBI chr15:351,065...1,057,117
Ensembl chr15:302,214...1,001,198
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Kl
Klotho
ISO
mRNA:decreased expression:kidney:
RGD
PMID:20004202
RGD:10403055
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:490,399...530,080
G
Mapk1
mitogen activated protein kinase 1
treatment
IEP
RGD
PMID:27028006
RGD:13800882
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:29037916
RGD:13800567
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mif
macrophage migration inhibitory factor
severity
ISO
RGD
PMID:15807847
RGD:36947390
NCBI chr20:12,767,138...12,791,222
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mir146a
microRNA 146a
ISO
miRNA:increased expression:colon, small intestine (mouse)
RGD
PMID:24092752
RGD:126925183
NCBI chr10:28,349,996...28,350,090
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
treatment
ISO IMP
associated with Helicobacter Infections
RGD
PMID:30927737 PMID:28461115 PMID:28752563 PMID:30253332 PMID:21880981 PMID:28246471 More...
RGD:21079443 , RGD:25314295 , RGD:24922208 , RGD:21081536 , RGD:21079473 , RGD:21079463
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
ameliorates
ISO
RGD
PMID:23826144
RGD:41404691
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
G
Mmp2
matrix metallopeptidase 2
treatment
IEP
RGD
PMID:23323009
RGD:13207328
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
treatment
IEP
RGD
PMID:23323009
RGD:13207328
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Msc
musculin
exacerbates no_association
ISO
RGD
PMID:33448336 PMID:36848960
RGD:596936211 , RGD:596936221
NCBI chr 5:9,330,522...9,336,391
Ensembl chr 5:4,547,405...4,553,203
G
Myd88
MYD88, innate immune signal transduction adaptor
exacerbates
ISO
RGD
PMID:25362351
RGD:150521530
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22350949
RGD:10412739
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
treatment
IDA
RGD
PMID:21642017
RGD:10413866
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nod2
nucleotide-binding oligomerization domain containing 2
IEP
protein:increased expression:colonic mucosa:
RGD
PMID:22997830
RGD:13204727
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Npy
neuropeptide Y
treatment
IMP
RGD
PMID:20533056
RGD:10448943
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:78,881,264...78,888,495
G
Pdgfra
platelet derived growth factor receptor alpha
treatment
IEP
RGD
PMID:24115822
RGD:11080973
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
treatment
IEP
RGD
PMID:24115822
RGD:11080973
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Phex
phosphate regulating endopeptidase X-linked
ISO
mRNA:decreased expression:bone:
RGD
PMID:16890604
RGD:11556253
NCBI chr X:41,422,561...41,671,226
Ensembl chr X:37,610,760...37,854,469
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
susceptibility
ISO
RGD
PMID:20347874
RGD:38599183
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:48,766,864...48,802,043
G
Ptger4
prostaglandin E receptor 4
treatment
IMP
RGD
PMID:12100473
RGD:727388
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:54,335,424...54,346,670
G
Rela
RELA proto-oncogene, NF-kB subunit
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rnasel
ribonuclease L
severity
ISO
RGD
PMID:23567782
RGD:40902808
NCBI chr13:68,446,641...68,460,804
Ensembl chr13:65,901,459...65,908,704
G
Slc11a1
solute carrier family 11 member 1
ISO
RGD
PMID:19116231
RGD:5684934
NCBI chr 9:83,406,327...83,417,252
Ensembl chr 9:75,957,316...75,968,101
G
Smad3
SMAD family member 3
ISO
protein:increased expression:colon
RGD
PMID:30064196
RGD:597830080
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Smad4
SMAD family member 4
susceptibility
ISO
RGD
PMID:23090737
RGD:12880038
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Socs3
suppressor of cytokine signaling 3
treatment
IEP
RGD
PMID:29572553
RGD:152995414
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Tnf
tumor necrosis factor
treatment
IMP IEP
RGD
PMID:21296062 PMID:29572553
RGD:8661763 , RGD:152995414
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
IMP
RGD
PMID:21296062
RGD:8661763
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Serpine1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:25656775
RGD:13208543
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Vegfa
vascular endothelial growth factor A
ISO
RGD
PMID:15770733
RGD:1580570
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Il1rn
interleukin 1 receptor antagonist
ISO
protein:increased concentration:serum (human)
RGD
PMID:9802632
RGD:6909134
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Abcb1a
ATP binding cassette subfamily B member 1A
susceptibility
ISO
RGD
PMID:15505619
RGD:1598568
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
ISO
mRNA:decreased expression:colonic mucosa
RGD
PMID:21987487
RGD:7241281
NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:174,133,288...174,160,184
G
Adcy7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28067910
NCBI chr19:34,913,154...34,972,366
Ensembl chr19:18,740,875...18,776,311
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:16432373
RGD:5686726
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adrb2
adrenoceptor beta 2
IEP
protein:decreased expression:large intestine mucosa,spleen
RGD
PMID:22772914
RGD:7175063
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Alox12
arachidonate 12-lipoxygenase, 12S type
ISO
protein:increased expression:large intestine epithelium
RGD
PMID:7679252
RGD:5509621
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:54,958,271...54,970,542
G
Alpi
alkaline phosphatase, intestinal
ISO
protein:decreased expression:colonic mucosa
RGD
PMID:22783049
RGD:14367879
NCBI chr 9:95,221,314...95,224,780
Ensembl chr 9:87,773,411...87,776,877
G
Apln
apelin
ISO
protein:increased expression:intestine
RGD
PMID:17391779
RGD:1626177
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:127,203,823...127,213,391
G
Apoa4
apolipoprotein A4
severity
ISO
DNA:missense mutation:cds:p.Q360H (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:35999755 PMID:17206692
RGD:5685660
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:46,539,082...46,541,469
G
Aqp7
aquaporin 7
severity
ISO
mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:56,172,519...56,186,642
G
Arpc2
actin related protein 2/3 complex, subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18836448
NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:75,820,770...75,851,471
G
Bcl6
BCL6, transcription repressor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:38164749
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:76,854,090...76,877,389
G
Brinp3
BMP/retinoic acid inducible neural specific 3
ISO
mRNA,protein:decreased expression:intestine
RGD
PMID:25171508
RGD:14398484
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:58,413,883...58,846,770
G
Btnl2
butyrophilin-like 2
susceptibility
ISO
DNA:SNPs: : rs2294881,rs9268480,rs2076523(human)
RGD
PMID:19659809
RGD:9685032
NCBI chr20:4,492,100...4,505,932
Ensembl chr20:4,489,517...4,503,341
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
G
Card9
caspase recruitment domain family, member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 3:29,569,907...29,578,402
Ensembl chr 3:9,171,815...9,180,237
G
Casp3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Ccl20
C-C motif chemokine ligand 20
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16306769 PMID:21887805
RGD:7488892
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
G
Ccl7
C-C motif chemokine ligand 7
ISO
protein:increased expression:colon
RGD
PMID:10433925
RGD:6483784
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,016,446...67,018,303
G
Ccny
cyclin Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr17:62,079,925...62,207,780
Ensembl chr17:57,384,176...57,522,378
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21077277
RGD:6892920
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:123,616,236...123,634,990
G
Ccr6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16306769
NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:52,474,168...52,498,603
G
Cd40
CD40 molecule
ISO
protein:increased expression:intestine, epithelial cell
RGD
PMID:20133813
RGD:5490590
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
G
Cdh3
cadherin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:34,393,727...34,444,084
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:15743319
RGD:8662406
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cfb
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
ISO
mRNA:increased expression:intestine:
RGD
PMID:27051591
RGD:151667910
NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:116,714,711...116,837,240
G
Col18a1
collagen type XVIII alpha 1 chain
IEP
Protein:increased expression:large intestine mucosa
RGD
PMID:17011522
RGD:1600887
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
ISO
RGD
PMID:17939044
RGD:5688304
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Col6a3
collagen type VI alpha 3 chain
ISO
protein:increased expression:serum (human)
RGD
PMID:32245981
RGD:401900121
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:91,361,583...91,439,471
G
Cxcr1
C-X-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:83,216,040...83,220,225
Ensembl chr 9:75,766,770...75,771,084
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
mRNA:increased expression:peripheral blood immature plasma cells (human)
RGD
PMID:21087446
RGD:6480657
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:66,844,318...66,846,969
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
mRNA:increased expression:peripheral blood immature plasma cells (human)
RGD
PMID:21087446
RGD:6480657
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
susceptibility
ISO
DNA:SNPs:multiple (human)
RGD
PMID:28811712
RGD:151665177
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:159,275,947...159,290,383
G
Dap
death-associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 2:83,910,113...83,962,673
Ensembl chr 2:82,199,280...82,251,752
G
Defa5
defensin alpha 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr16:77,044,994...77,047,318
Ensembl chr16:70,342,530...70,344,836
G
Dpep1
dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr19:68,118,270...68,143,781
Ensembl chr19:51,219,660...51,235,257
G
Duox2
dual oxidase 2
ISO
mRNA:increased expression:colon (human)
RGD
PMID:19759286
RGD:40924645
NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:109,226,924...109,245,902
G
Ecm1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406
NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:183,287,322...183,292,671
G
Ephb2
Eph receptor B2
ameliorates
IDA
RGD
PMID:33722292
RGD:127285641
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:148,897,246...149,077,059
G
Esr2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21593018
RGD:5147754
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
Fas
Fas cell surface death receptor
treatment
IEP
RGD
PMID:30122878
RGD:13792562
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
treatment
IEP
RGD
PMID:30122878
RGD:13792562
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fcgr2a
Fc gamma receptor 2A
susceptibility
ISO
DNA:polymorphism: :p.A519G (human) CTD Direct Evidence: marker/mechanism DNA:SNP: :rs1801274 (human)
CTD RGD
PMID:19915573 PMID:20228799 PMID:20848524 PMID:19915573
RGD:5147918 , RGD:5147922
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:83,280,784...83,295,967
G
Fgf7
fibroblast growth factor 7
ISO
mRNA:increased expression:colon, lamina propria, myofibroblasts (human)
RGD
PMID:9358773
RGD:126928145
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:113,281,283...113,332,929
G
Gc
GC, vitamin D binding protein
susceptibility
ISO
DNA:polymorphism:cds:p.T420K(human)
RGD
PMID:21832969
RGD:5509866
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,632,135...18,667,567
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19617644
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:146,865,712...146,869,621
G
Gna12
G protein subunit alpha 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:13,805,698...13,886,255
G
Gpr65
G-protein coupled receptor 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30616622
NCBI chr 6:123,245,534...123,262,758
Ensembl chr 6:117,515,648...117,536,512
G
Gpx1
glutathione peroxidase 1
ISO
protein:decreased expression:erythrocyte
RGD
PMID:20186929
RGD:11352754
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
disease_progression
ISO
protein:increased expression:large intestine (human)
RGD
PMID:18479189
RGD:152998902
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:17565649 PMID:28626742 PMID:26604430
RGD:5490554 , RGD:14700999 , RGD:11538341
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:17565649 PMID:26604430
RGD:5490554 , RGD:11538341
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Herc2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 1:116,009,681...116,243,888
Ensembl chr 1:106,880,084...107,108,134
G
Hnf4a
hepatocyte nuclear factor 4, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320
G
Hnmt
histamine N-methyltransferase
ISO
RGD
PMID:18340362
RGD:5509777
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:6,591,463...6,624,012
G
Hp
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hspa4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:colon mucosa, epithelium (human)
RGD
PMID:22297444
RGD:5688753
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,408,025...37,449,001
G
Htra1
HtrA serine peptidase 1
ISO
protein:decreased expression:colonic epithelium,colonic mucosa (human)
RGD
PMID:28586045
RGD:152985530
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:185,497,735...185,547,379
G
Icam1
intercellular adhesion molecule 1
IEP ISO
mRNA:increased expression:substantia nigra (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15553846 PMID:20584104
RGD:4145388
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Icoslg
inducible T-cell co-stimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr20:10,600,078...10,610,385
Ensembl chr20:10,600,420...10,610,703
G
Igf1r
insulin-like growth factor 1 receptor
ISO
protein:altered expression:colon
RGD
PMID:18938767
RGD:5686432
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Igf2
insulin-like growth factor 2
disease_progression
ISO
RGD
PMID:16088202
RGD:5509966
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:197,814,410...197,823,018
G
Ikzf1
IKAROS family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr14:90,468,696...90,556,522
Ensembl chr14:86,255,065...86,342,416
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18836448 PMID:20228799 PMID:26660358 PMID:28120341
RGD:14975255 , RGD:14975153
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799 PMID:21297633
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il18rap
interleukin 18 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:42,768,220...42,800,959
G
Il1b
interleukin 1 beta
IEP ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12133438 PMID:15955209 PMID:20452301 PMID:22119283 PMID:24812904
RGD:10450593
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:42,384,433...42,424,725
G
Il1rn
interleukin 1 receptor antagonist
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
RGD
PMID:8119534
RGD:6909136
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il23r
interleukin 23 receptor
ISO
DNA:SNP,Haplotype: :rs1884444(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18438406 PMID:19122664 PMID:20228799 PMID:23093364
RGD:8549574
NCBI chr 4:97,910,230...98,003,759
Ensembl chr 4:96,580,714...96,674,021
G
Il33
interleukin 33
severity treatment
ISO
mRNA:increased expression:sigmoid colon
RGD
PMID:25112700 PMID:21037074 PMID:28802904
RGD:39938951 , RGD:40813742 , RGD:39938966
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:227,721,435...227,736,373
G
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:58,454,217...58,477,757
G
Irf4
interferon regulatory factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38164749
NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,721,811...33,740,070
G
Irf5
interferon regulatory factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 4:59,092,914...59,104,596
Ensembl chr 4:58,127,640...58,139,267
G
Irgm
immunity-related GTPase M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,233,455...33,241,578
G
Jak2
Janus kinase 2
ISO
DNA:SNP: :rs10758669 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20228799 PMID:21297633 PMID:22269120
RGD:6483020
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,217,871...32,261,018
G
Kif21b
kinesin family member 21B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr13:50,127,842...50,177,822
Ensembl chr13:47,576,160...47,626,127
G
Lamb1
laminin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:47,835,525...47,902,585
G
Lsp1
lymphocyte-specific protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:197,614,687...197,648,416
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16640825 PMID:35999755
NCBI chr 8:119,878,344...119,901,189
Ensembl chr 8:110,999,948...111,022,795
G
Masp2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 5:164,319,017...164,332,686
Ensembl chr 5:159,035,911...159,049,580
G
Mir155
microRNA 155
ISO
miRNA:decreased expression:feces miRNA:increased expression:colon
RGD
PMID:30927737 PMID:29668922 PMID:29325325 PMID:29438285
RGD:21079443 , RGD:24922213 , RGD:24922207 , RGD:21403682
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir31
microRNA 31
ISO
miRNA:increased expression:colon
RGD
PMID:29438285
RGD:21403682
NCBI chr 5:108,714,849...108,714,954
G
Mmp1
matrix metallopeptidase 1
IDA
RGD
PMID:18837084
RGD:7207395
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:4,658,588...4,679,097
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22119283
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20380826 PMID:22119283 PMID:24055189
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mst1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799
NCBI chr 8:117,646,485...117,652,016
Ensembl chr 8:108,768,839...108,773,416
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:polymorphism: :66A>G (human)
RGD
PMID:21947961
RGD:5508217
NCBI chr 1:36,695,376...36,727,341
Ensembl chr 1:34,867,089...34,899,425
G
Muc2
mucin 2, oligomeric mucus/gel-forming
IEP
mRNA:altered expression: :
RGD
PMID:12870797
RGD:2324685
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:196,799,517...196,831,756
G
Nkx2-3
NK2 homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405 PMID:18438406 PMID:20228799
NCBI chr 1:252,427,356...252,430,309
Ensembl chr 1:242,478,130...242,481,083
G
Nod2
nucleotide-binding oligomerization domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:18,382,439...18,417,177
G
Ormdl3
ORMDL sphingolipid biosynthesis regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:84,086,317...84,092,673
Ensembl chr10:83,590,071...83,598,620
G
Pon1
paraoxonase 1
ISO
mRNA:decreased expression:colon (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Pon3
paraoxonase 3
ISO
mRNA:decreased expression:colon (human)
RGD
PMID:17664137
RGD:5509924
NCBI chr 4:34,323,546...34,350,244
Ensembl chr 4:33,349,168...33,383,855
G
Prdm1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr20:49,542,465...49,564,088
Ensembl chr20:47,959,858...47,981,488
G
Psmg1
proteasome assembly chaperone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr11:48,745,581...48,755,040
Ensembl chr11:35,276,011...35,285,622
G
Ptger4
prostaglandin E receptor 4
ISO
RGD
PMID:21818367
RGD:6483532
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:54,335,424...54,346,670
G
Ptgs1
prostaglandin-endoperoxide synthase 1
IMP
RGD
PMID:17429720
RGD:2300267
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:17429720
RGD:2300267
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr18:63,498,890...63,564,571
Ensembl chr18:61,229,014...61,294,627
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15955209
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Ripk2
receptor-interacting serine-threonine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:29,631,570...29,662,657
G
RT1-Bb
RT1 class II, locus Bb
ISO
RGD
PMID:31038770
RGD:14865009
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25559196
NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,548,666...4,558,258
G
Sell
selectin L
ISO
DNA:polymorphism: :p.F206L (human)
RGD
PMID:19212205
RGD:13464267
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:76,416,915...76,436,456
G
Selp
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21526498
RGD:6218993
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:76,476,295...76,511,845
G
Slc11a1
solute carrier family 11 member 1
ISO
DNA:transition, repeat:promoter:-237C>T (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human)
CTD RGD
PMID:16059695 PMID:18340647 PMID:11929588
RGD:5684939 , RGD:5684968
NCBI chr 9:83,406,327...83,417,252
Ensembl chr 9:75,957,316...75,968,101
G
Slc26a3
solute carrier family 26 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915573
NCBI chr 6:53,751,415...53,792,300
Ensembl chr 6:48,023,892...48,064,772
G
Sphk1
sphingosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr10:102,257,413...102,263,086
Ensembl chr10:101,758,711...101,764,240
G
Stat3
signal transducer and activator of transcription 3
ISO
DNA:SNP: :rs744166 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18438405 PMID:20228799 PMID:22269120
RGD:6483020
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Thbd
thrombomodulin
ISO
protein:decreased expression:colon, blood vessel
RGD
PMID:17557119
RGD:5685011
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Tnf
tumor necrosis factor
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
CTD RGD
PMID:19617644 PMID:20452301 PMID:22119283 PMID:25204186 PMID:28120341 PMID:24812904 More...
RGD:10450577 , RGD:14975153 , RGD:10450593
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
severity
ISO
mRNA,protein:increased expression, decreased expression:colonic mucosa (human)
RGD
PMID:28842689
RGD:151347619
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Tnfsf15
TNF superfamily member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 5:82,150,376...82,171,743
Ensembl chr 5:77,139,878...77,156,228
G
Tp53
tumor protein p53
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15553846
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:plasma, large intestine mucosa
RGD
PMID:19013462
RGD:5684406
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vip
vasoactive intestinal peptide
severity
ISO
mRNA:decreased expression:colon
RGD
PMID:22143367
RGD:5685619
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:42,065,120...42,073,216
G
Vipr1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:17611633
RGD:5685618
NCBI chr 8:130,181,219...130,217,098
Ensembl chr 8:121,310,248...121,339,585
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all